# GHK-Cu: The Copper Peptide Research Field Guide > GHK-Cu is the copper(II) tripeptide studied across 50+ publications for collagen synthesis, skin repair, and hair follicle stimulation. A plain-language field guide to what the research actually shows. ## What Is GHK-Cu and What Does the Research Show? GHK-Cu — glycyl-L-histidyl-L-lysine copper(II) complex — is a tripeptide that forms naturally in human plasma, saliva, and urine. It is the copper-chelated form of the free tripeptide GHK, and that copper coordination is essential: the copper-free form shows significantly reduced potency in fibroblast assays [1]. Molecular weight 401.91 Da, CAS 89030-95-5, INCI name Copper Tripeptide-1. The compound's research history begins with Loren Pickart's 1973 discovery that human serum promoted liver tissue regeneration in culture; the active fraction turned out to be GHK-Cu. Over the following five decades, more than 50 peer-reviewed publications have characterized its behavior across dermal fibroblast cultures, rodent wound models, hair follicle systems, lung tissue, skeletal muscle, and the gut epithelium. At its core, GHK-Cu acts as a copper chaperone — concentrating bioavailable Cu(II) at wound sites and cell surfaces. From there it activates multiple repair pathways simultaneously: TGF-beta receptor upregulation, Nrf2/Keap1 antioxidant defense, NF-kappaB anti-inflammatory suppression, Wnt/beta-catenin hair follicle signaling, and SIRT1-dependent metabolic protection [4]. ## GHK vs GHK-Cu: The Role of Copper Chelation GHK is the free tripeptide — glycyl-L-histidyl-L-lysine (MW 340.38 Da). GHK-Cu is the copper(II) chelate of the same sequence. The two are related but not interchangeable. Copper coordination happens via the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and the deprotonated glycine-histidine amide nitrogen, forming a stable 1:1 molar complex. That coordination geometry is what enables the biological activities documented in the literature [1]. In direct fibroblast-culture comparisons, copper-free GHK has significantly reduced potency in collagen synthesis assays. ## GHK-Cu Copper Peptide: Research-Documented Benefits The peer-reviewed record across five decades documents GHK-Cu effects in six domains: **Collagen and skin matrix.** GHK-Cu stimulated collagen synthesis in human dermal fibroblast cultures at picomolar to nanomolar concentrations — stimulation began at 10^-12 M, maximized at 10^-9 M, and did not depend on cell proliferation [1]. Upregulation extends beyond type I collagen to types III and IV, elastin, glycosaminoglycans, and the small proteoglycan decorin [5]. **Gene expression modulation.** Microarray analysis of the Broad Institute Connectivity Map dataset found GHK modulated approximately 31.2% of human genes (4,278 with >=50% expression change) — 59% upregulated, 41% downregulated. Pathways affected included ubiquitin-proteasome integrity (41 genes up, 1 down), DNA repair (47 up, 5 down), and antioxidant defense (14 up, 2 prooxidant genes down) [2]. **Hair follicle activation.** A randomized double-blind six-month trial in 45 males with androgenetic alopecia found a GHK peptide complex (ALAVAX) significantly increased hair count at a 1-cm diameter area (52.6–71.5 new hairs vs 9.6 in placebo, p<0.05) with no adverse events [6]. **Wrinkle and elasticity improvement.** A human volunteer trial with GHK-Cu in a nanocarrier formulation reduced facial wrinkle volume by 31.6% compared to a benchmark peptide (Matrixyl 3000) and by 55.8% vs untreated control; wrinkle depth decreased by 32.8% vs control (all p<0.012) [18]. **Lung and systemic protection.** GHK-Cu at 0.2–20 μg/g/day IP attenuated cigarette-smoke-induced emphysema in mice by activating the Nrf2/Keap1 antioxidant pathway, reducing IL-1beta and TNF-alpha, and correcting the MMP-9/TIMP-1 imbalance [9]. **Age-related decline and reversal.** Plasma GHK drops from approximately 200 ng/mL at age 20 to under 80 ng/mL by age 60 — a greater-than-60% reduction [3]. In aged mouse fibroblasts, GHK treatment reduced senescence markers p21 and p53, restored migration capacity and collagen gel contraction, and activated stemness markers p63 and PCNA [11]. ## Why Does GHK-Cu Decline With Age? GHK is not synthesized by cells as a standalone product — it is released by injury-activated proteinases hydrolyzing the alpha2(I) chain of type I collagen. Plasma GHK peaks around 10^-7 M (approximately 200 ng/mL) in young adults and declines to under 80 ng/mL by age 60, a reduction of more than 60% [3]. In human COPD patients, plasma GHK was significantly lower (70.27 ± 38.87 ng/mL) than in healthy controls (133.0 ± 54.54 ng/mL) and correlated positively with skeletal muscle mass and the antioxidant enzyme SOD2 [10]. ## The Anti-Aging Research Case for GHK-Cu The evidence base for GHK-Cu in aging biology is stronger than most cosmetic peptides: more than 50 peer-reviewed publications, a well-characterized mechanism, documented human-trial results in collagen synthesis and wrinkle depth, and recent work in cognitive aging and skeletal muscle preservation. In aging mice given intranasal GHK-Cu (15 mg/kg/day for 8 weeks), spatial working memory and navigation learning improved significantly; neuroinflammation marker MCP-1 decreased and axonal damage marker NFL-1 was reduced in both sexes [15]. A 2024 study in aged mouse fibroblasts showed GHK reversed the myofibroblast senescence phenotype via integrin-beta1 signaling [11]. The primary limitation: most studies are rodent models or small-scale human trials, several are industry-sponsored, and independent replication of Pickart's broader gene-expression claims remains limited. ## References [1] Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988;238(2):343-346. https://pubmed.ncbi.nlm.nih.gov/3169264/ [2] Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: Resetting the Human Genome to Health. BioMed Research International. 2014;2014:151479. https://pmc.ncbi.nlm.nih.gov/articles/PMC4180391/ [3] Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/ [4] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/ [5] Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988. https://pubmed.ncbi.nlm.nih.gov/18644225/ [6] Lee WJ et al. Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Annals of Dermatology. 2016;28(4):438-443. https://pmc.ncbi.nlm.nih.gov/articles/PMC4969472/ [9] Zhang Q et al. Glycyl-L-histidyl-L-lysine-Cu2+ attenuates cigarette smoke-induced pulmonary emphysema. Frontiers in Molecular Biosciences. 2022;9:925700. https://pmc.ncbi.nlm.nih.gov/articles/PMC9354777/ [10] Deng M et al. Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction. Journal of Cachexia, Sarcopenia and Muscle. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10235902/ [11] He Q, Mazzola J, Ladiges W. The naturally occurring peptide GHK reverses age-related fibrosis. Aging Pathobiology and Therapeutics. 2024;6(4):186-190. https://pmc.ncbi.nlm.nih.gov/articles/PMC12352503/ [15] Tucker M et al. Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. Aging Pathobiology and Therapeutics. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10680828/ [18] Badenhorst T et al. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. Journal of Aging Science. 2016;4:166. --- Plain-language summaries of the peer-reviewed copper-peptide record — cited study by study, chapter by chapter, sold by no one.